BRIDGEWAY CAPITAL MANAGEMENT, LLC - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 55 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$534,000
-27.3%
35,000
-41.7%
0.01%
-28.6%
Q2 2018$735,000
-7.7%
60,000
-28.0%
0.01%
-22.2%
Q1 2018$796,000
-41.2%
83,300
-44.4%
0.01%
-40.0%
Q4 2017$1,354,000
+39.9%
149,900
-10.9%
0.02%
+36.4%
Q3 2017$968,000
+227.0%
168,300
+80.4%
0.01%
+175.0%
Q2 2017$296,000
-6.6%
93,3000.0%0.00%0.0%
Q1 2017$317,000
+17.8%
93,3000.0%0.00%0.0%
Q4 2016$269,000
-51.0%
93,3000.0%0.00%
-50.0%
Q3 2016$549,000
+92.0%
93,300
+75.0%
0.01%
+60.0%
Q1 2016$286,000
-61.9%
53,300
-15.8%
0.01%
-64.3%
Q4 2015$751,000
+44.4%
63,3000.0%0.01%
+27.3%
Q3 2015$520,000
-17.2%
63,300
+40.7%
0.01%
-8.3%
Q2 2015$628,000
-41.9%
45,0000.0%0.01%
-45.5%
Q1 2015$1,081,000
+45.9%
45,0000.0%0.02%
+29.4%
Q4 2014$741,00045,0000.02%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,355,392$29,859,0006.21%
Bain Capital Life Sciences Investors, LLC 3,080,237$67,858,0004.26%
DAFNA Capital Management LLC 587,756$12,948,0003.85%
SILVERARC CAPITAL MANAGEMENT, LLC 227,388$5,009,0002.91%
RTW INVESTMENTS, LP 7,253,857$159,802,0002.68%
Parkman Healthcare Partners LLC 331,513$7,303,0001.87%
Evolutionary Tree Capital Management, LLC 60,864$1,341,0001.02%
Eagle Health Investments LP 69,000$1,520,0000.97%
Woodline Partners LP 1,358,796$29,934,0000.79%
Affinity Asset Advisors, LLC 40,000$881,0000.47%
View complete list of DICERNA PHARMACEUTICALS INC shareholders